AIとがん研究 ── がん一般 ── 2026-11-16
がん一般 4 本。筆頭: HGS-BioAbductor: hypergraph-based explainable survival modelling and LLM-based biological hypothesis abduction
がん一般の分子生物学の進展とAI
- HGS-BioAbductor: hypergraph-based explainable survival modelling and LLM-based biological hypothesis abduction抄録(全訳)掲載誌の IF 相当:9.8(OpenAlex の直近 2 年の平均被引用数・2026-11-04 時点の値、2026-11-05 に取得。正式な IF(Clarivate)ではない)書誌:Chen Y, Zhang Q, Jiang P, Xie L. HGS-BioAbductor: hypergraph-based explainable survival modelling and LLM-based biological hypothesis abduction. npj Precis Onc. 2026 Nov 14 [Epub ahead of print]. doi:10.1038/s41698-026-01764-9.確認の範囲:抄録のみ確認
- Interpretable machine learning model based on gray-scale ultrasound image for noninvasive prediction of BPGT and MPGT抄録(全訳)掲載誌の IF 相当:4.8(OpenAlex の直近 2 年の平均被引用数・2026-11-12 時点の値、2026-11-13 に取得。正式な IF(Clarivate)ではない)書誌:Mao Y, Peng XQ, Jiang LP, Diao YH, Wang JL, Chen FQ, et al. Interpretable machine learning model based on gray-scale ultrasound image for noninvasive prediction of BPGT and MPGT. BMC Cancer. 2026 Nov 14 [Epub ahead of print]. doi:10.1186/s12885-026-17264-9.確認の範囲:抄録のみ確認
- The deep learning framework Hist2Prot infers single-cell spatial proteomics from histology to predict biomarkers and clinical outcomes抄録(全訳)掲載誌の IF 相当:21.7(OpenAlex の直近 2 年の平均被引用数・2026-11-13 時点の値、2026-11-15 に取得。正式な IF(Clarivate)ではない)書誌:Fan J, Yang S, Hu E, An J, Liu Q, Liu N, et al. The deep learning framework Hist2Prot infers single-cell spatial proteomics from histology to predict biomarkers and clinical outcomes. Nat Cancer. 2026 Nov 13 [Epub ahead of print]. doi:10.1038/s43018-026-01270-8.確認の範囲:抄録のみ確認
- Artificial intelligence on routine haematoxylin and eosin slides to prioritise BRCA and homologous recombination deficiency testing in ovarian, breast, prostate and pancreatic cancer: a diagnostic accuracy systematic review and meta-analysis抄録(全訳)掲載誌の IF:不明(照合できず)書誌:[No authors listed]. Artificial intelligence on routine haematoxylin and eosin slides to prioritise BRCA and homologous recombination deficiency testing in ovarian, breast, prostate and pancreatic cancer: a diagnostic accuracy systematic review and meta-analysis. Open Science Framework. [Epub ahead of print]. doi:10.17605/osf.io/xud4t.確認の範囲:抄録のみ確認